Publications

Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals.

Neuen BL. et al, (2026), Nat Med

Positive Predictive Value of Respiratory Infection Diagnoses in The Danish National Patient Registry: a Post-hoc Validation Analysis of the DANFLU-1 Trial.

Christensen J. et al, (2026), Int J Infect Dis

Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.

Zhu D. et al, (2026), Am J Kidney Dis, 87, 564 - 568

Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.

Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.

Nielsen AB. et al, (2026), JAMA Intern Med, 186, 311 - 320

Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.

Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists' (CTT) Collaboration ., (2026), Lancet, 407, 689 - 703

Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial.

Bernholm KF. et al, (2026), Eur J Clin Microbiol Infect Dis

Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial.

Espersen C. et al, (2026), J Infect Dis, 233, e89 - e98

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2026), Lancet Infect Dis, 26, 34 - 45

A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.

Johansen ND. et al, (2026), Am Heart J, 291, 186 - 198

Characteristics of interventional clinical trials registered in ClinicalTrials.gov, 2018-2023.

Sullenger RD. et al, (2026), J Clin Transl Sci, 10

High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis.

Bartholdy KV. et al, (2025), J Am Coll Cardiol, 86, 2636 - 2647

High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation: A Prespecified Analysis of the DANFLU-2 Trial.

Espersen C. et al, (2025), J Am Coll Cardiol, 86, 2651 - 2655

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.

Johansen ND. et al, (2025), N Engl J Med, 393, 2291 - 2302

Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis.

Estrella MM. et al, (2025), JAMA, 334, 1915 - 1926

Cookies on this website

Search results (318)